Cosmos Health (COSM) Operating Leases (2019 - 2026)
Cosmos Health's (COSM) quarterly Operating Leases came in at $432422.0 in Q2 2026, down 4.64% on a YoY basis from $453442.0 in Q2 2025, and down 6.68% quarter-over-quarter from $463388.0 in Q1 2026.
Analysis
Cosmos Health (COSM) Operating Leases (2019 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Operating Leases for 8 consecutive years, with $432422.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases fell 4.64% year-over-year to $432422.0; the trailing twelve-month figure through Jun 2026 stood at $432422.0 (down 4.64% YoY), and the FY2025 full-year result was $373473.0, down 25.07% from the prior year.
- Operating Leases fell to $432422.0 in Q2 2026 per COSM's latest filing, from $463388.0 in the prior quarter.
- Across five years, Operating Leases topped out at $919711.0 in Q1 2023 and bottomed at $373473.0 in Q4 2025.
- Historically, Operating Leases has averaged $579234.9 across 5 years, with a median of $503642.5 in 2024.
- The sharpest annual moves came in 2023 and 2024: Operating Leases surged 49.02% in 2023, then sank 44.67% in 2024.
- Over 5 years, Operating Leases stood at $828762.0 in 2022, then advanced by 1.94% to $844866.0 in 2023, then slumped by 41.01% to $498398.0 in 2024, then slipped by 25.07% to $373473.0 in 2025, then advanced by 15.78% to $432422.0 in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $432422.0, $463388.0, and $373473.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 432,422.00 |
| Mar 31, 2026 | 463,388.00 |
| Dec 31, 2025 | 373,473.00 |
| Sep 30, 2025 | 427,813.00 |
| Jun 30, 2025 | 453,442.00 |
| Mar 31, 2025 | 466,909.00 |
| Dec 31, 2024 | 498,398.00 |
| Sep 30, 2024 | 468,157.00 |
| Jun 30, 2024 | 471,697.00 |
| Mar 31, 2024 | 508,887.00 |
| Dec 31, 2023 | 844,866.00 |
| Sep 30, 2023 | 628,179.00 |
| Jun 30, 2023 | 695,005.00 |
| Mar 31, 2023 | 919,711.00 |
| Dec 31, 2022 | 828,762.00 |
| Sep 30, 2022 | 604,746.00 |
| Jun 30, 2022 | 723,190.00 |
| Mar 31, 2022 | 617,183.00 |
| Dec 31, 2021 | 696,015.00 |
| Sep 30, 2021 | 739,832.00 |